Publisher： Bentham Science Publishers
E-ISSN： 1873-4286|23|39|5971-5972
ISSN： 1381-6128
Source： Current Pharmaceutical Design, Vol.23, Iss.39, 2018-02, pp. : 5971-5972
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
MiRNA-based Therapeutics for Lung Cancer
Current Pharmaceutical Design, Vol. 23, Iss. 39, 2018-02 ,pp. :
Access to resources
Recommend
MiRNA-based Therapeutic Strategy in Lung Cancer
Current Pharmaceutical Design, Vol. 23, Iss. 39, 2018-02 ,pp. :
Role of miRNA in Lung Cancer-Potential Biomarkers and Therapies
Current Pharmaceutical Design, Vol. 23, Iss. 39, 2018-02 ,pp. :
Lipid Nanoparticles to Deliver miRNA in Cancer
Current Pharmaceutical Biotechnology, Vol. 17, Iss. 8, 2016-07 ,pp. :